BR9712274A - Composição hormonal consistindo de um composto de estrogênio e um composto progestacional - Google Patents
Composição hormonal consistindo de um composto de estrogênio e um composto progestacionalInfo
- Publication number
- BR9712274A BR9712274A BR9712274-2A BR9712274A BR9712274A BR 9712274 A BR9712274 A BR 9712274A BR 9712274 A BR9712274 A BR 9712274A BR 9712274 A BR9712274 A BR 9712274A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- progestational
- hormonal
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
"COMPOSIçãO HORMONAL CONSISTINDO DE UM COMPOSTO DE ESTROGêNIO E UM COMPOSTO PROGESTACIONAL".A presente invenção refere-se ao campo da terapia e mais particularmente ao capo da técnica hormonal farmacêutica. Mais precisamtnte, refere-se a novas composições hormonais farmacêuticas caracterizadas pelo fato das mesmas serem formadas por uma combinação estroprogestacional consisitindo de um composto de estrogênio e um composto progestacional, associado ou uma misturado com um ou vários excipientes farmaceuticamente inertes e não tóxicos aceitácies, para a administração oral. A presente invenção refere-se também ao uso da mistura estroprogestacional na qual o constituinte estrogênico e o constituinte progestacional são administrados em combinação. A associação combinada pode ser prescrita continuamente ou intermitentemente, para a produção de uma composição para o tratamento das doenças estrogênicas, prevenção da osteoporose e doenças cardiovasculares em mulheres em menopausa, ou ainda bloqueando a ovulação em mulheres durante o período de atividade ovariana. A presente invenção refere-se também a um método de preparação das referidas novas composições farmacêuticas estroprogestacionais.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9612239A FR2754179B1 (fr) | 1996-10-08 | 1996-10-08 | Nouvelle composition hormononale et son utilisation |
| PCT/FR1997/001792 WO1998015279A1 (fr) | 1996-10-08 | 1997-10-08 | Composition hormonale constituee d'un compose estrogene et d'un compose progestatif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9712274A true BR9712274A (pt) | 1999-08-31 |
Family
ID=9496456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9712274-2A BR9712274A (pt) | 1996-10-08 | 1997-10-08 | Composição hormonal consistindo de um composto de estrogênio e um composto progestacional |
Country Status (38)
| Country | Link |
|---|---|
| US (4) | US6831073B1 (pt) |
| EP (2) | EP1334725B1 (pt) |
| JP (1) | JP4883542B2 (pt) |
| KR (2) | KR100782638B1 (pt) |
| CN (3) | CN1239893A (pt) |
| AP (1) | AP1171A (pt) |
| AR (2) | AR009113A1 (pt) |
| AT (2) | ATE238057T1 (pt) |
| AU (1) | AU745571B2 (pt) |
| BR (1) | BR9712274A (pt) |
| CA (1) | CA2268358C (pt) |
| CL (1) | CL2011000017A1 (pt) |
| CZ (1) | CZ298402B6 (pt) |
| DE (3) | DE69721314T2 (pt) |
| DK (2) | DK1334725T3 (pt) |
| DZ (1) | DZ2327A1 (pt) |
| ES (2) | ES2198006T3 (pt) |
| FR (2) | FR2754179B1 (pt) |
| HK (1) | HK1210708A1 (pt) |
| HU (2) | HU227450B1 (pt) |
| ID (1) | ID21569A (pt) |
| IL (1) | IL129194A (pt) |
| LU (1) | LU91932I2 (pt) |
| MA (1) | MA24370A1 (pt) |
| MY (1) | MY128482A (pt) |
| NO (3) | NO324357B1 (pt) |
| NZ (1) | NZ334876A (pt) |
| OA (1) | OA11033A (pt) |
| PL (1) | PL192979B1 (pt) |
| PT (2) | PT956022E (pt) |
| RU (1) | RU2274450C2 (pt) |
| SK (2) | SK285056B6 (pt) |
| TN (1) | TNSN97164A1 (pt) |
| TR (1) | TR199900764T2 (pt) |
| TW (1) | TW491704B (pt) |
| WO (1) | WO1998015279A1 (pt) |
| YU (1) | YU18099A (pt) |
| ZA (1) | ZA979011B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| DE19549264A1 (de) * | 1995-12-23 | 1997-06-26 | Schering Ag | Verfahren und Kit zur Kontrazeption |
| WO2001030355A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| WO2001030356A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
| FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
| FR2823976A1 (fr) * | 2001-04-25 | 2002-10-31 | Theramex | Nouvelle composition hormonale et son utilisation |
| UY29185A1 (es) * | 2004-11-02 | 2006-05-31 | Schering Ag | Formas de dosificación oral sólidas que contienen una dosis baja de estradiol |
| AR065816A1 (es) | 2007-03-26 | 2009-07-01 | Theramex | Regimen anticonceptivo oral |
| US20080293683A1 (en) * | 2007-05-24 | 2008-11-27 | University Of Kansas Medical Center | Hormone Replacement Therapy |
| TW200930343A (en) * | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
| US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
| WO2015086489A1 (en) | 2013-12-11 | 2015-06-18 | Merck Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
| KR20240005348A (ko) | 2022-07-05 | 2024-01-12 | 신규식 | 소멸특허 관리 및 특허거래 시스템 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3271392A (en) * | 1965-09-14 | 1966-09-06 | American Home Prod | 17alpha-[3'-furyl]-estrogens |
| US4390531A (en) | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| US4921843A (en) | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
| US4826831A (en) | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| US4628051A (en) | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| JPS61243059A (ja) | 1985-04-19 | 1986-10-29 | Konishi Kagaku Kogyo Kk | 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法 |
| ZA87332B (en) | 1986-02-27 | 1987-08-26 | Warner Lambert Co | Compositions containing fixed combinations |
| US5208225A (en) | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
| IE61236B1 (en) | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
| CA1332227C (en) | 1987-09-24 | 1994-10-04 | Robert F. Casper | Oral contraceptive formulation |
| NZ226316A (en) * | 1987-09-24 | 1991-10-25 | Jencap Research Ltd | Pharmaceutical contraceptive preparations and packages containing from 20-35 unit dosages comprising an estrogen and a progestin; the unit dosages having alternating estrogen and progestin dominance |
| US5108995A (en) | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| US5256421A (en) | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
| US5276022A (en) | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
| HUT52382A (en) | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
| IE71203B1 (en) | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
| IE62665B1 (en) | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
| FR2695826B1 (fr) * | 1992-09-21 | 1995-01-06 | Theramex | Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention. |
| US6150343A (en) | 1993-06-30 | 2000-11-21 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
| DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| US5552394A (en) * | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
| US6613757B1 (en) | 1994-09-22 | 2003-09-02 | Board Of Regents, The University Of Texas System | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| SE9403389D0 (sv) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
| FR2737411B1 (fr) * | 1995-08-01 | 1997-10-17 | Theramex | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
| DE19540253C2 (de) | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
| DE19549264A1 (de) | 1995-12-23 | 1997-06-26 | Schering Ag | Verfahren und Kit zur Kontrazeption |
| WO1997041871A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
| WO1997041870A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
| WO1997041868A1 (en) | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
| AU2926797A (en) | 1996-05-08 | 1997-11-26 | American Home Products Corporation | Oral contraceptive |
| AU2746097A (en) | 1996-05-08 | 1997-11-26 | American Home Products Corporation | Oral contraceptive |
| US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
| DK0917466T3 (da) | 1996-07-26 | 2004-12-20 | Wyeth Corp | Oralt antikonceptionsmiddel |
| AU3961697A (en) | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
| WO1998004267A1 (en) | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
| DE69724796T2 (de) | 1996-07-26 | 2004-07-01 | Wyeth | Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten |
| AU3888597A (en) | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
| WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| DE19705229C2 (de) | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| WO1999009993A1 (en) | 1997-08-27 | 1999-03-04 | Ortho Pharmaceutical Corporation | Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception |
| DE19739916C2 (de) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| AU759925B2 (en) | 1997-09-12 | 2003-05-01 | Wyeth | Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin |
| WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
-
1996
- 1996-10-08 FR FR9612239A patent/FR2754179B1/fr not_active Expired - Fee Related
-
1997
- 1997-10-07 TN TNTNSN97164A patent/TNSN97164A1/fr unknown
- 1997-10-08 AT AT97944940T patent/ATE238057T1/de active
- 1997-10-08 EP EP03008979A patent/EP1334725B1/fr not_active Expired - Lifetime
- 1997-10-08 WO PCT/FR1997/001792 patent/WO1998015279A1/fr active IP Right Grant
- 1997-10-08 IL IL12919497A patent/IL129194A/xx not_active IP Right Cessation
- 1997-10-08 AP APAP/P/1999/001500A patent/AP1171A/en active
- 1997-10-08 DE DE69721314T patent/DE69721314T2/de not_active Expired - Lifetime
- 1997-10-08 HU HU9904508A patent/HU227450B1/hu active Protection Beyond IP Right Term
- 1997-10-08 CN CN97180380A patent/CN1239893A/zh active Pending
- 1997-10-08 CN CN201510024865.6A patent/CN104706641A/zh active Pending
- 1997-10-08 RU RU2003107072/15A patent/RU2274450C2/ru active
- 1997-10-08 CN CNA2007101694575A patent/CN101229173A/zh active Pending
- 1997-10-08 CZ CZ0112099A patent/CZ298402B6/cs not_active IP Right Cessation
- 1997-10-08 DK DK03008979T patent/DK1334725T3/da active
- 1997-10-08 MY MYPI97004717A patent/MY128482A/en unknown
- 1997-10-08 NZ NZ334876A patent/NZ334876A/xx not_active IP Right Cessation
- 1997-10-08 SK SK438-99A patent/SK285056B6/sk not_active IP Right Cessation
- 1997-10-08 KR KR1020067013702A patent/KR100782638B1/ko not_active IP Right Cessation
- 1997-10-08 SK SK5098-2005A patent/SK285455B6/sk active Protection Beyond IP Right Term
- 1997-10-08 US US09/284,147 patent/US6831073B1/en not_active Expired - Lifetime
- 1997-10-08 DZ DZ970177A patent/DZ2327A1/xx active
- 1997-10-08 TR TR1999/00764T patent/TR199900764T2/xx unknown
- 1997-10-08 DE DE69737373T patent/DE69737373T2/de not_active Expired - Lifetime
- 1997-10-08 CA CA2268358A patent/CA2268358C/fr not_active Expired - Lifetime
- 1997-10-08 YU YU18099A patent/YU18099A/sh unknown
- 1997-10-08 EP EP97944940A patent/EP0956022B1/fr not_active Expired - Lifetime
- 1997-10-08 JP JP51726398A patent/JP4883542B2/ja not_active Expired - Lifetime
- 1997-10-08 PL PL332610A patent/PL192979B1/pl unknown
- 1997-10-08 MA MA24828A patent/MA24370A1/fr unknown
- 1997-10-08 AR ARP970104638A patent/AR009113A1/es not_active Application Discontinuation
- 1997-10-08 ZA ZA9709011A patent/ZA979011B/xx unknown
- 1997-10-08 KR KR1019990703032A patent/KR20000048981A/ko not_active IP Right Cessation
- 1997-10-08 ES ES97944940T patent/ES2198006T3/es not_active Expired - Lifetime
- 1997-10-08 AU AU46273/97A patent/AU745571B2/en not_active Expired
- 1997-10-08 ID IDW990211A patent/ID21569A/id unknown
- 1997-10-08 PT PT97944940T patent/PT956022E/pt unknown
- 1997-10-08 PT PT03008979T patent/PT1334725E/pt unknown
- 1997-10-08 AT AT03008979T patent/ATE353652T1/de active
- 1997-10-08 DK DK97944940T patent/DK0956022T3/da active
- 1997-10-08 ES ES03008979T patent/ES2282539T3/es not_active Expired - Lifetime
- 1997-10-08 BR BR9712274-2A patent/BR9712274A/pt not_active Application Discontinuation
- 1997-10-15 TW TW086115281A patent/TW491704B/zh not_active IP Right Cessation
-
1999
- 1999-03-31 NO NO19991593A patent/NO324357B1/no not_active IP Right Cessation
- 1999-04-08 OA OA9900078A patent/OA11033A/fr unknown
- 1999-10-25 US US09/423,108 patent/US6906049B1/en not_active Expired - Lifetime
-
2004
- 2004-01-08 US US10/753,073 patent/US20040220163A1/en not_active Abandoned
-
2007
- 2007-01-03 US US11/649,672 patent/US7749987B2/en not_active Expired - Fee Related
-
2009
- 2009-10-26 AR ARP090104109A patent/AR073972A2/es not_active Application Discontinuation
-
2011
- 2011-01-06 CL CL2011000017A patent/CL2011000017A1/es unknown
-
2012
- 2012-01-13 LU LU91932C patent/LU91932I2/fr unknown
- 2012-01-19 FR FR12C0005C patent/FR12C0005I2/fr active Active
- 2012-01-23 DE DE201212000010 patent/DE122012000010I1/de active Pending
- 2012-01-24 NO NO2012002C patent/NO2012002I2/no not_active IP Right Cessation
- 2012-01-26 HU HUS1200002C patent/HUS1200002I1/hu unknown
-
2015
- 2015-11-24 HK HK15111561.9A patent/HK1210708A1/xx unknown
-
2017
- 2017-08-08 NO NO2017043C patent/NO2017043I2/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6451779B1 (en) | Composition and method for contraception and treatment of tumors of the mammary glands | |
| BR9712274A (pt) | Composição hormonal consistindo de um composto de estrogênio e um composto progestacional | |
| CA2302700A1 (en) | New use for budesonide and formoterol | |
| BR0109334A (pt) | Terapia de reposição hormonal | |
| DK0402950T3 (da) | Behandling af postmenopausale ulemper | |
| BRPI0416924A (pt) | preparação farmacêutica para tratamento hormonal contìnuo durante um perìodo de mais do que 21-28 dias compreendendo duas composições de estrogênio e/ou progestina | |
| EA200301022A1 (ru) | Гормональная заместительная терапия | |
| AP1849A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| NZ312303A (en) | Novel nor-pregnanes for inducing hypothalamic effects | |
| AP1625A (en) | Hormonal composition based on a progesterone and an oestrogen and use thereof. | |
| BR0114665A (pt) | Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio | |
| RU2188641C2 (ru) | Новые гормональные лекарственные препараты и их применение для коррекции эстрогенной недостаточности | |
| NO955085D0 (no) | Androstansteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder | |
| HK1087039A1 (en) | Use of biphosphonate in preparing medical kit and a kit used for increasing bone mass | |
| JP2942560B2 (ja) | エストロゲン欠乏症治療用組成物 | |
| NO955084D0 (no) | Estrensteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder | |
| BR0014952A (pt) | Medicamento contraceptivo e seu modo de preparação | |
| RU2000115313A (ru) | Схемы приема гестаген-анти-гестагена | |
| AR033260A1 (es) | Nueva composicion hormonal y su utilizacion | |
| EP0692965A1 (en) | Method and composition for treatment of osteoporosis | |
| EP1178807B1 (en) | Use of org 33245 in combined intermittent hormone therapy and contraception | |
| JPH0692856A (ja) | エストリオールの高血中濃度が得られる軟膏剤 | |
| MXPA94000705A (es) | Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados. | |
| FR2791572A1 (fr) | Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables | |
| JPH05194239A (ja) | 卵巣欠落によるのぼせ治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO COM BASE NOS ARTIGOS 11 E 13 COMBINADO COM O ARTIGO 37 DA LEI 9.279 DE 14/05/1996. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B25B | Requested transfer of rights rejected |
Owner name: LABORATOIRE THERAMEX SA (MC) |
|
| B25B | Requested transfer of rights rejected |
Owner name: LABORATOIRE THERAMEX SA (MC) |